Globus Medical (GMED) Tops Q1 EPS by 2c, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports First Quarter 2015 Results
May 5, 2015 4:10 PM EDTAUDUBON, Pa.--(BUSINESS WIRE)-- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2015.
Worldwide sales increased 15.2% to $131.6 million, or 16.4% on a constant currency basis Net income increased 16.6% to $24.6 million Fully diluted earnings per share (EPS) were $0.26 Non-GAAP Adjusted EBITDA was 35.2% of sales Company increases 2015 guidance for sales to $514 million and EPS to $1.02David Paul,... More
